Tularemia: an experience of 13 cases including a rare myocarditis in a referral center in Eastern Switzerland (Central Europe) and a review of the literature.
Francisella tularensis
Glandular tularemia
Myocarditis
Oculoglandular tularemia
Pulmonary tularemia
Tularemia
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
12
10
2018
accepted:
06
01
2019
pubmed:
19
1
2019
medline:
6
2
2020
entrez:
19
1
2019
Statut:
ppublish
Résumé
Tularemia, a zoonotic disease caused by Francisella tularensis, can cause a broad spectrum of disease in humans including six major clinical presentations: the ulceroglandular, glandular, oculoglandular, oropharyngeal, typhoidal and pneumonic form. The epidemiology and ecology and thus transmission of tularemia are complex, depending on conditions unique to specific locations. Thirteen cases with different forms of the disease and one very rare case of a myocarditis are reported, discussed, and reviewed within the scope of current literature. Tularemia is a rare, but emerging disease in Central Europe with glandular and ulceroglandular disease as its predominant forms. Transmission is mainly caused by contact with lagomorphs, rodents and tick bites. However, domestic cats may play an important role in transmission too. Myocarditis is probably a worldwide, but very rare manifestation of tularemia.
Sections du résumé
BACKGROUND
BACKGROUND
Tularemia, a zoonotic disease caused by Francisella tularensis, can cause a broad spectrum of disease in humans including six major clinical presentations: the ulceroglandular, glandular, oculoglandular, oropharyngeal, typhoidal and pneumonic form. The epidemiology and ecology and thus transmission of tularemia are complex, depending on conditions unique to specific locations.
CASE SERIES AND METHODS
UNASSIGNED
Thirteen cases with different forms of the disease and one very rare case of a myocarditis are reported, discussed, and reviewed within the scope of current literature.
CONCLUSION
CONCLUSIONS
Tularemia is a rare, but emerging disease in Central Europe with glandular and ulceroglandular disease as its predominant forms. Transmission is mainly caused by contact with lagomorphs, rodents and tick bites. However, domestic cats may play an important role in transmission too. Myocarditis is probably a worldwide, but very rare manifestation of tularemia.
Identifiants
pubmed: 30656604
doi: 10.1007/s15010-019-01269-7
pii: 10.1007/s15010-019-01269-7
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
683-695Références
Ellis J, Oyston PCF, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15:631–46.
doi: 10.1128/CMR.15.4.631-646.2002
Tärnvik A, Berglund L. Tularaemia. Eur Respir J. 2003;21:361–73. https://doi.org/10.1183/09031936.03.00088903 .
doi: 10.1183/09031936.03.00088903
pubmed: 12608453
Tularämie, Hasenpest—Ein Überblick. Bundesamt für Gesundh. BAG. 2012. https://www.bag.admin.ch/bag/de/home/themen/mensch-gesundheit/uebertragbare-krankheiten/infektionskrankheiten-a-z/tularaemie.html . Accessed 5 Jan 2017.
Keim P, Johansson A, Wagner DM. Molecular epidemiology, evolution, and ecology of Francisella. Ann N Y Acad Sci. 2007;1105:30–66. https://doi.org/10.1196/annals.1409.011 .
doi: 10.1196/annals.1409.011
pubmed: 17435120
Penn RL. 229—Francisella tularensis (Tularemia). In: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 2015. [cited 2017 Aug 20]. pp. 2590–2602.e3. http://www.sciencedirect.com/science/article/pii/B9781455748013002290 .
Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1–29. https://doi.org/10.1196/annals.1409.009 .
doi: 10.1196/annals.1409.009
pubmed: 17395726
Mailles A, Vaillant V. 10 years of surveillance of human tularaemia in France. Eurosurveillance 2014;19:20956. https://doi.org/10.2807/1560-7917.ES2014.19.45.20956
doi: 10.2807/1560-7917.ES2014.19.45.20956
pubmed: 25411688
Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, et al. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis. 2012;18:1484–6.
doi: 10.3201/eid1809.111856
Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113–24.
doi: 10.1016/S1473-3099(15)00355-2
Kugeler KJ, Janusz AM, Staples JE, Kubota KA, Chalcraft LG, Petersen JM. Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis. 2009;48:863–70. https://doi.org/10.1086/597261 .
doi: 10.1086/597261
pubmed: 19245342
Farlow J, Wagner DM, Dukerich M, Stanley M, Chu M, Kubota K, et al. Francisella tularensis in the United States. Emerg Infect Dis. 2005;11:1835–41.
doi: 10.3201/eid1112.050728
Alias T, Fallahzadeh MK, Berhe M. Tularemia presenting as pulmonary nodules in an immunocompromised patient. Bayl Univ Med Cent Proc. 2017;30:175–6.
doi: 10.1080/08998280.2017.11929573
Franzen D, Müller F, Bode PK. Lung mass and tularaemia. QJM. 2016;109:417–8.
doi: 10.1093/qjmed/hcv221
Odegaard K, Boersma B, Keegan J. Atypical presentations of tularemia. S D Med U S. 2017;70:207–9.
Naughton M, Brown R, Adkins D, DiPersio J. Tularemia—an unusual cause of a solitary pulmonary nodule in the post-transplant setting. Bone Marrow Transpl. 1999;24:197–9.
doi: 10.1038/sj.bmt.1701863
Fachinger P, Tini GM, Grobholz R, Gambazzi F, Fankhauser H, Irani S. Pulmonary tularaemia: all that looks like cancer is not necessarily cancer—case report of four consecutive cases. BMC Pulm Med. 2015;15:1–6.
doi: 10.1186/s12890-015-0026-y
Genchi M, Prati P, Vicari N, Manfredini A, Sacchi L, Clementi E, et al. Francisella tularensis: no evidence for transovarial transmission in the tularemia tick vectors dermacentor reticulatus and ixodes ricinus. PLoS One. 2015;10:e0133593.
doi: 10.1371/journal.pone.0133593
Johansson A, Lärkeryd A, Widerström M, Mörtberg S, Myrtännäs K, Öhrman C, et al. An outbreak of respiratory tularemia caused by diverse clones of Francisella tularensis. Clin Infect Dis. 2014;59:1546–53.
doi: 10.1093/cid/ciu621
Eliasson H, Lindbäck J, Pekka Nuorti J, Arneborn M, Giesecke J, Tegnell A. The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis. 2002;8:956–60.
doi: 10.3201/eid0809.020051
Capellan J, Fong IW. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis. 1928;16:472–5.
doi: 10.1093/clind/16.4.472
Petersson E, Athlin S. Cat-bite-induced Francisella tularensis infection with a false-positive serological reaction for Bartonella quintana. JMM Case Rep. 2017;4:4–7. https://doi.org/10.1099/jmmcr.0.005071 .
doi: 10.1099/jmmcr.0.005071
Larson MA, Fey PD, Hinrichs SH, Iwen PC. Francisella tularensis bacteria associated with feline tularemia in the United States. Emerg Infect Dis. 2014;20:2068–71.
doi: 10.3201/eid2012.131101
Shaw SE, Birtles RJ, Day MJ. Arthropod-transmitted infectious diseases of cats. J Feline Med Surg. 2001;3:193–209.
doi: 10.1053/jfms.2001.0149
Federal Office of Public Health FOPH Switzerland. https://www.bag.admin.ch/bag/de/home/zahlen-undstatistiken/zahlen-zu-infektionskrankheiten.exturl.html . Accessed 1 Dec 2017.
Ernst M, Pilo P, Fleisch F, Glisenti P. Tularemia in the Southeastern Swiss Alps at 1,700 m above sea level. Infection. 2015;43:111–5.
doi: 10.1007/s15010-014-0676-3
Tärnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci. 2007;404:378–404.
doi: 10.1196/annals.1409.017
Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol. 2004;17:489–95.
doi: 10.1038/modpathol.3800087
Erdem H, Ozturk-Engin D, Yesilyurt M, Karabay O, Elaldi N, Celebi G, et al. Evaluation of tularaemia courses: a multicentre study from Turkey. Clin Microbiol Infect. 2014;20:O1042–51. https://doi.org/10.1111/1469-0691.12741 .
doi: 10.1111/1469-0691.12741
pubmed: 24975504
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Tularemia as a biological weapon: medical and public health management. JAMA U S. 2001;285:2763–73.
doi: 10.1001/jama.285.21.2763
WHO guidelines on tularaemia. WHO Libr. Cat. Data. 2007.
Caspar Y, Hennebique A, Maurin M. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016. J Antimicrob Chemother Engl. 2017;73:687–91.
doi: 10.1093/jac/dkx460
Tomaso H, Hotzel H, Otto P, Myrtennas K, Forsman M. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany. J Antimicrob Chemother England. 2017;72:2539–43.
doi: 10.1093/jac/dkx182
Ulu-Kilic A, Gulen G, Sezen F, Kilic S, Sencan I. Tularemia in central Anatolia. Infect Ger. 2013;41:391–9.
doi: 10.1007/s15010-012-0355-1
Meric M, Willke A, Finke E-J, Grunow R, Sayan M, Erdogan S, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS Den. 2008;116:66–73.
doi: 10.1111/j.1600-0463.2008.00901.x
Pérez-Castrillón JL, Bachiller-Luque P, Martín-Luquero M, Mena-Martín FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis U S. 2001;33:573–6.
doi: 10.1086/322601
Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis. 1994;19:42–7.
doi: 10.1093/clinids/19.1.42
Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med U S. 1987;147:265–8.
doi: 10.1001/archinte.1987.00370020083041
Eliasson H, Back E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis Engl. 2007;39:880–9.
doi: 10.1080/00365540701402970
Risi GF, Pombo DJ. Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis U S. 1995;20:174–5.
doi: 10.1093/clinids/20.1.174
Origgi FC, Frey J, Pilo P. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013. Eurosurveillance 2014;19:1–10.
doi: 10.2807/1560-7917.ES2014.19.29.20858
Borde JP, Zange S, Antwerpen MH, Georgi E, von Buttlar H, Kern WV, et al. Five cases of vector-borne Francisella tularensis holarctica infections in south-western Germany and genetic diversity. Ticks Tick Borne Dis Neth. 2017;8:808–12.
doi: 10.1016/j.ttbdis.2017.06.009
Dentan C, Pavese P, Pelloux I, Boisset S, Brion J-P, Stahl J-P, et al. Treatment of tularemia in pregnant woman. Fr Emerg Infect Dis U S. 2013;19:996–8.
doi: 10.3201/eid1906.130138
Maurin M, Pelloux I, Brion JP, Del Bano J-N, Picard A. Human tularemia in France, 2006–2010. Clin Infect Dis U S. 2011;53:e133-41.
Johansson A, Berglund L, Sjöstedt A, Tärnvik A. Ciprofloxacin for treatment of tularemia. Clin Infect Dis U S. 2001;33:267–8.
doi: 10.1086/321825
Syrjala H, Schildt R, Raisainen S. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis Ger. 1991;10:68–70.
doi: 10.1007/BF01964409
Bloch-Infanger C, Furrer K, Wiese M, Hiebinger A, Bucher CM, Kopp S, et al. An unexpected cause for cavitary pneumonia and empyema. Infect Ger. 2016;44:539–41.
doi: 10.1007/s15010-015-0861-z
Celebi G, Baruonu F, Ayoglu F, Cinar F, Karadenizli A, Ugur MB, et al. Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis Jpn. 2006;59:229–34.
Passiouk N, Heininger U. Ulceroglandular tularemia following contact with a boar. Pediatr Infect Dis J U S. 2016;35:453–5.
doi: 10.1097/INF.0000000000001027
Franco Hidalgo S, Prieto de Paula JM, Balaguer Zubieta I, Alvarez Ruiz AP. Infection due to Francisella tularensis, myocarditis and dilated myocardiopathy. Enferm Infecc Microbiol Clin. 2010;28:752–3.
doi: 10.1016/j.eimc.2010.01.011
Amort J, Karrer U. Zwei Fallbeispiele zur Tularämie: eine typische und eine atypische Verlaufsform. BAG Bull. 2013;(49/13):896
Gore I, Saphir O. myocarditis a classification of 1402 cases. Am Heart J. 1947;34(6):827–30.
doi: 10.1016/0002-8703(47)90147-6
Saphir O. Myocarditis A general review, with an analysis of two hundred an forty cases. Arch Pathol. 1941. https://doi.org/10.1179/nhi.1988.24.1.227 .
doi: 10.1179/nhi.1988.24.1.227
Saphir O. Isolated myocarditis. Am Heart J. 1942;24:167–81.
doi: 10.1016/S0002-8703(42)90856-1
Aaagard GN. Involvement of the heart in tularemia. Minn Med. 1944;27:115–21
Miller J. Granulomatous myocarditis. A case for diagnosis. Can Med Assoc J. 1933;29:134–7.
pubmed: 20319194
pmcid: 402959
Ilback NG, Friman G, Beisel WR, Johnson AJ. Sequential metabolic alterations in the myocardium during influenza and tularemia in mice. Infect Immun. 1984;45:491–7.
pubmed: 6746101
pmcid: 263270